Chair
Executive Committee
Vice Chair
Pam Randhawa
Founder & CEO, Empiriko
Treasurer
Michael O’Hara
Partner, Deloitte
Counsel
Larry Wittenberg
Partner, Goodwin
Clerk
Chris Garabedian
Chairman & CEO, Xontogeny
Immediate Past Chair
David Lucchino
Co-founder, President & CEO, Frequency Therapeutics
Directors
Lisa Adler
Managing Partner, RAZR Consulting
Laurie Bartlett Keating
EVP, General Counsel & Secretary, Alnylam Pharmaceuticals, Inc.
Udit Batra
President & CEO, Waters Corporation
Cheryl Blanchard
President & CEO, Anika Therapeutics, Inc.
Melissa Bradford-Klug
President & Chief Business Officer, RareStone Inc.
Tim P. Clackson
President & CEO, Theseus Pharmaceuticals
Chip Clark
President & CEO, Genocea Biosciencs, Inc.
Sharon Cload
Vice President, Discovery Biotherapeutics, East Coast, Bristol Myers Squibb
Jason Cole
Chief Operating & Legal Officer, bluebird bio
Robert Coughlin
Managing Director, Life Sciences, JLL
Troy Cox
Chairman Sophia Genetics, Vice Chairman LetsGetChecked and Board Director at Zymeworks, BioSplice & Somalogic
Christopher de Souza
Director, Broadview Ventures
John Dunlop
Chief Scientific Officer
Jeff Elton
CEO, Concerto Health Ai
Barbara S. Fox
CEO, Rheos Medicines
Gary Gillheeney
President & CEO, Organogenesis Inc.
Robert Gottlieb
Principal, RMG Associates
Luba Greenwood
Managing Partner, Binney Street Capital
Jose-Carlos Gutierrez-Ramos, Ph.D.
CSO, Danaher Corporation
Scott H. Gillis
President, Pericor Science, Inc.
Sue Hager
Chief Investor Relations & Communications Officer, Section 32 Ventures
Martin Heidecker
Managing Director, AMR Action Fund
Amit K. Sachdev
Executive VP, CPO, COS, Vertex
Ed Kaye
CEO, Stoke Therapeutics
Chris Leibman
SVP, Value and Access, Biogen
Mark Leuchtenberger
Executive Chairman, Aleta Biotherapeutics
Lizabeth Leveille
Vice President and Head, BD&L Boston & European Innovation Hubs, Merck & Co., Inc.
Liz Lewis
Head of Global Oncology Patient Value, Policy and Access, Takeda
Alice Lin Pomponio
Managing Director, American Cancer Society’s BrightEdge Fund
David Meeker
CEO, Rhythm Therapeutics
Christopher Murphy
Vice President/General Manager, Viral Vector Services, Thermo Fisher Scientific
Gilmore O’Neill
Executive Vice President, R&D, & Chief Medical Officer, Sarepta
William P. McDermott
Partner, McDermott, Quilty & Miller LLP
Cindy Perettie
Head, Roche Molecular Labs
Adelene Perkins
CEO & Chair, Infinity Pharmaceuticals
Michal Preminger
Head, Johnson & Johnson Innovation, East North America
Chandra Ramanathan
Global Head, Pharma R&D Open Innovation, Bayer
Eric Rasmussen
Vice President, Government Relations & Public Affairs, Sunovion
Richard Russell
CEO, TRACT Pharmaceuticals
Bill Sibold
Executive Vice President & Head, Sanofi Genzyme
Barbara Sosnowski
Vice President & ES&I Head, Pfizer
Kumar Srinivasan
Executive Vice President & CBO, Turning Point Therapeutics
Tamar Thompson
Head, Corporate Affairs, Alexion, AstraZeneca Rare Disease
